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Multi-segmented dsRNA viruses have been suggested to utilize cis-acting elements in the plus-strand
RNA to accomplish genomic RNA assortment during viral packaging. It is not clear if bi-segmented dsRNA
birnavirus uses the same strategy. By applying a reverse genetic technique, we generated IBDV particles
packaged with only segment A by co-transfection DF-1 cells of cDNA from segment A and VP1 (without
50 and 30 noncoding region of segment B) supporting random assortment mechanism and indicating the
packaging elements of segment B include sequences in the 50 and 3′ NCR. However, gfp-containing IBDV
could not be generated in the presence of gfp cDNA constructs ﬂanked by 50 and 30 NCR from segment A
or segment B. The data suggest additional packaging signals are required for IBDV genomic packaging.
The presence of VP1 protein in the IBDV-A particles also suggests the formation of ribonucleoprotein
(RNP) complexes might be involved in the assembly of viral particles.
& 2015 Elsevier Inc. All rights reserved.Introduction
Successful packaging of complete viral genome component is
necessary for the viral progeny to be infectious. The speciﬁc
selection can be achieved by utilizing cis-acting elements as the
packaging signals to ensure genomic incorporation as well as to
tell apart from the cellular nucleic acids. Segmented RNA viruses
have one more challenge to take: to encapsidate at least one copy
of each genomic segment into the assembling particles. Seg-
mented RNA viruses are proposed to use either random or selec-
tive strategy for genomic assortment and packaging. For multi-
segmented dsRNA viruses such as rotavirus, cis-acting elements
reside in 50 and 30 noncoding regions (NCR) of plus-strand RNAs
(þRNAs) are thought to determine segment selection (McDonald
and Patton, 2011). The coding sequences within the open reading
frames (ORFs) are not necessary for assortment and packaging and
can be partially replaced and still form viruses (Roner and Joklik,
2001). On the other hand, less is known for bi-segmented dsRNA
viruses in the Birnaviridae family. Birnavirus has been shown to be
very different from multi-segmented dsRNA viruses in the Reo-
viridae family. Although both viruses have nonenveloped, icosa-
hedral capsid, the capsid of birnavirus is composed of a single
layer of VP2 (T¼13) while the capsid of reovirus possess multiple
concentric shells (Coulibaly et al., 2005; Li et al., 2009). Inside the
capsid, the 50 ends of the segment A and segment B are covalentlyniversity, ADDL, 406 South
USA. Tel.: þ1 765 4947927;linked to VP1, the RNA-dependent RNA polymerase encoded by
segment B (Calvert et al., 1991). Furthermore, the dsRNA of bir-
navirus is also associated with the VP3 nucleocapsid protein,
together with VP1 forming ribonucleoprotein (RNP) complexes
(Luque et al., 2009b; Tacken et al., 2002). These RNP complexes
have the ability to initiate replication cycle without the VP2 capsid
protein (Dalton and Rodríguez, 2014). The structure and replica-
tion differences described above between birnavirus and reovirus
support the idea that birnavirus might use a different strategy for
their genome assortment and packaging.
Infectious bursal disease virus (IBDV) one of the prototype
birnaviruses has been shown to be a polyploid virus (Luque et al.,
2009a). The polyploidy feature of IBDV indicates that birnavirus
might utilize random assortment strategy for genome packaging.
Because polyploidy allows viral particles to pack up to 4 genomic
dsRNA segments and it signiﬁcantly increases the chance for the
progeny viruses to contain both segment A and segment B within
the same viral particle (Luque et al., 2009a). With random
assortment strategy, cis-acting packaging/selection elements are
still necessary to discriminate viral RNAs from cellular RNAs. The
predicted secondary structure of IBDV þRNAs showed features
shared by both segments including a 50 long stem loop and a 30
stem loop with free cytosine tails formed by 50 and 30 interaction,
suggesting these structures within the 50 and 30 NCR might be
involved in viral genome packaging (Mosley et al., 2013). However,
it is not clear if any viral proteins are involved with genomic RNA
encapsidation for IBDV.
In the present study, we provided evidence to conﬁrm that
IBDV employed random assortment to package its genome by
utilizing the reverse genetics system. Our results also showed the
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Fig. 1. Characterization of IBDV-A particles by EM and Western blotting. IBDV-A particles were concentrated by sucrose cushion and puriﬁed by CsCl gradient centrifugation.
Puriﬁed IBDV-A particles (a) have similar viral particle morphology and size to those of IBDV WT control (b). Puriﬁed IBDV-A particles were also subjected to Western
blotting with primary antibody against VP2 (c), VP1 (d) or VP3 (e). Lane 1 represents IBDV-A viral particles and lane 2 was the IBDV WT control.
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these signals alone were not enough for genomic packaging. In
addition, VP1 and/or RNPs might be required for genomic
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Fig. 2. Genome composition of IBDV-A particles. dsRNAs extracted from IBDV-A
viral particles (lane 1) and IBDV-WT (lane 2) by the proteinase K method were
examined in a 0.6% native agaorse gel.Results
IBDV particles packaged with only SegA can be formed by reverse
genetics
By co-transfection of cDNA of segment A (SegA) and segment B
(SegB), IBDV-WT could be generated from DF-1 cells (Mosley et al.,
2013). To investigate if the packaging elements reside in the 50 and
30 NCR of IBDV genomic RNA, we attempted to generate IBDV with
SegA and a modiﬁed SegB without 50 and 30 NCR (only the ORF of
segment B in a pcDNA vector), named SegAþVP1. The transfection
of SegAþVP1 was able to produce viral-like particles and these
particles were further characterized and compared to those of
IBDV-WT. We found out these particles have the same appearance
and size to IBDV-WT under electron microscope (Fig. 1a and b). In
addition, these particles composed the same viral proteins as
IBDV-WT such as pVP2/VP2, VP3 and VP1 (Fig. 1c–e). We then
examined the genomic composition of these particles by electro-
phoresis and conﬁrmed these particles were packaged with only
SegA (Fig. 2), hence named IBDV-A viral particles. The absence of
SegB RNA in the viral particles was also conﬁrmed by RT-PCR (data
not shown). Plaque assay of IBDV-A viral particles showed no
plaque formation (data not shown) indicating these particles
cannot complete its life cycle in infected cells to produce progeny.
Our results showed that IBDV-A particles obtained from
transfection of SegA and VP1 were IBDV-like particles packaged
only with SegA dsRNA. The fact that these IBDV-like particles
could be packaged with only one population of segment indicatedthat the packaging process of IBDV dsRNA does not require the
interaction between the two genomic segments and provided
evidence to support random assortment strategy. Our results also
suggested that the cis-acting packaging elements of IBDV at least
for SegB might include sequences in 50 and 30 NCR since VP1
dsRNAwas not packaged in IBDV-A particles when 50 and 30 NCR of
SegB were missing.
Signals reside in 50 and 30 noncoding regions of IBDV genomic RNA are
not enough for genomic packaging
To elucidate if the genomic RNA packaging elements for SegB
resided in 50 and 30 noncoding regions (NCR), we performed co-
transfection of SegAþSegB with an additional cDNA construct of
green ﬂuorescence protein (GFP) ﬂanked by 50 and 30 NCR of SegA or
SegB (Fig. 3a). The expression of GFP was conﬁrmed by IFA in
transfected cells. However, the viruses collected from transfection
contained only IBDV-WT (generated by SegAþSegB), no gfp-encoding
Fig. 3. The transcript of SegA-gfp and SegB-gfp could not be encapsidated into IBDV. To elucidate if 50 and 30 NCR are sufﬁcient for genome packaging by IBDV, GFP-expressing
cDNA containing the 50 and 30 NCR of SegA or SegB were constructed (a). DF-1 cells were transfected with either SegA-gfp or SegB-gfp for 24 h, followed by IBDV infection
(MOI¼10). After 16 h of IBDV infection, cells were ﬁxed with paraformaldehyde and submitted to IFA for GFP (green) or VP2 (red) protein expression. White arrow points to
the cells co-expresses GFP and VP2 (yellow) (40 ).
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for gfp sequence from viral particles and there was no GFP expression
in those IBDVs-infected cell by IFA (data not shown). To further
conﬁrm this ﬁnding, we infected DF-1 cells with IBDV-LP1 strain
(MOI¼10) followed by transfection of SegA-gfp or SegB-gfp or per-
formed transfection ﬁrst followed by IBDV infection. Although the
expression of GFP and IBDV VP2 was conﬁrmed by IFA in infected
and transfected cells (Fig. 3b), the obtained IBDVs did not contain any
dsRNA genome with gfp sequence nor express GFP in infected cells
(data not shown). Our data suggested that cis-acting elements in the
50 and 30 NCR sequences are not sufﬁcient for IBDV genomic packa-
ging and there is additional packaging signal required for packaging
both segments.
VP1 is required for efﬁcient IBDV-A viral particle formation
To examine if VP1 is necessary to form IBDV-A viral particles,
we compared the transfection of SegA alone and SegAþVP1. The
expression of vp2 in transfected cells was conﬁrmed by RT-PCR
(Fig. 4a) and expression of vp1 was only found in SegAþVP1
transfected cells (Fig. 4b). However, there was no IBDV-A viral
particles generated after transfection from SegA alone. While there
was cytopathic effect (CPE) caused by SegAþVP1, DF-1 cells
remained healthy upon infection from supernatant collected from
SegA transfection (Fig. 4c). The absence of viral protein expression
was further conﬁrmed by IFA. VP2 and VP1 proteins were not
detected in cells infected with the supernatant collected from
SegA transfection. On the other hand, both viral proteins were
found in SegAþVP1 infected DF-1 cells (Fig. 4d and e). This results
suggested that the existence of VP1 is necessary to generate IBDV-
A viral particles. It has been shown that co-exist of VP1, VP3 and
dsRNA forms RNP complexes for IBDV. We suspect RNP complexes
were formed in IBDV-A particles since VP1 and VP3 were detected
by Western blotting (Fig. 1d and e) and dsRNA of SegA were
revealed by electrophoresis (Fig. 2). Hence, coordination of repli-
cation (RNP complex formation) and encapsidation may be the
mechanism IBDV employs for genomic packaging.Discussion
Our data provided direct evidence for IBDV random assort-
ment as well as showed that the cis-acting packaging elements
reside in the 50 and 30 NCR, but additional signal is required to
fulﬁll genome packaging. It would be interesting to compensate
the 50 NCR and 30 NCR separately back to the VP1/pcDNA con-
struct to conﬁrm if both NCRs are required for IBDV genome
packaging.
It has been reported that the expression of pVP2-VP4-VP3, the
second ORF in SegA could result in the formation of viral-like particles
(VLPs) in mammalian or insect cells (Fernández-Arias et al., 1998;
Kibenge et al., 1999). In our results, the efﬁciency of VLPs from SegA
transfection was quite low since only a few VP2-expressing cells were
detected by IFA when the supernatant from transfection was used to
infect DF-1 cells. The expression of SegA ORFs (including VP5 and
pVP2-VP4-VP3) was enhanced by co-transfection of VP1 (since VP1 is
the RNA-dependent RNA polymerase). But we argue this enhance-
ment was not the reason we obtained IBDV-A particles. It has been
known that VP3 is required to provide the scaffold to initiate the viral
capsid assembly process (Saugar et al., 2010). During capsid assembly,
VP3 also interacts with VP1 (Tacken et al., 2002). This interaction not
only brings VP1 into viral capsid but also makes IBDV particle for-
mation more efﬁciently (Lombardo et al., 1999). In addition, VP3, VP1
and genomic dsRNAs can form RNP complexes inside the capsid
which have the transcription and replication ability (Luque et al.,
2009b). We suspect RNP complexes were generated in IBDV-A parti-
cles. However, due to the lack of SegB dsRNA, IBDV-A viral particles
could not synthesize VP1 þRNA and thus there was no active VP1 in
the infected cells and no IBDV progeny could be generated after the
second round of infection. It is possible that encapsidation of the IBDV
genome is coupled with RNP complex formation.
The IBDV non-structural protein, VP5 is related to inducing cell
apoptosis. Interesting, when we performed immunostaining in
SegAþVP1 transfected cells, we observed cell membrane-associated
VP5 expression, but not in SegA-transfected cells (Fig. S1). We
suspected the existence of VP1 helped and possibly regulated the
Fig. 4. VP1 is required for IBDV-A particles formation. Expression of vp1 and vp2 from transfection was conﬁrmed by RT-PCR. RNA was extracted from transfected DF-1 cells
and followed by RT-PCR for vp2 gene (350 bp) (a) and vp1 gene (454 bp) (b). The RT-PCR template of lane 1 was from SegAþVP1 transfected cells, lane 2 was from SegA
transfected cells, and lane 3 was from mock transfected cells. DF-1 cells were infected with supernatant collected from transfection of SegA, SegAþVP1 or mock transfection
for 48 h (c). Immunoﬂuorescence antibody assay for VP2 (d) and VP1 (e) in infected cells (40 ).
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expression might be the cause of CPE we observed in the infectivity
test for IBDV-A viral particles (Fig. 4c).
In summary, we have shown that IBDV particles containing
only segment A could be assembled by the presence of VP1 pro-
tein. The cis-acting packaging elements for IBDV segment B RNA
encapsidation include sequences in the 50 and 30 NCR sequence
and the packaging process does not require the interaction
between the two segments. However, additional packaging signal
is required for IBDV genome packaging. Based on our previous
publication, the þRNA of segment A and segment B share similar
predicted secondary structure at 50 and 30 NCR (Mosley et al.,
2013). Whether these structures are the components of cis-actingsignals for IBDV packaging or there are cis-acting signals in the
ORF warrant further investigation.Materials and methods
Obtaining IBDV-A viral particles
DF-1 cells (ATCC, Manassas, VA, USA) were co-transfected with
SegA and VP1/pcDNA with Lipofectamine™ 2000 (Invitrogen,
Carlsbad, CA, USA) and collected as described previously (Mosley
et al., 2014) with collecting time at 48 h.
Y.-Y.C. Mosley et al. / Virology 488 (2016) 68–7272Electron microscopy for IBDV-A viral particles
IBDV-A viral particles were produced by co-transfection in DF-1
cells by TransITs-LT1 (Mirus Bio, Madison, WI, USA) in 14 6-wells.
After 48 h of transfection, supernatant and cells were collected by
scraping and subjected to freeze-thawed cycles for three times.
IBDV-A viral particles were collected by centrifugation at 2 krpm
for 20 min at 20 °C and concentrated by sucrose cushion (25%
sucrose) in SW28 tubes (Optima XL-100K, Beckman Coulter, Brea,
CA, USA) at 25 krpm for 3 h at 4 °C. Then, IBDV-A viral particles
were puriﬁed by CsCl gradient (1.327 g/ml) in SW41 Ti rotor
(Optima XL-100K, Beckman Coulter) at 25.8 krpm for 18 h at 4 °C
and washed with TNE buffer (10 mM Tris–HCl, pH 7.2; 100 mM
NaCl; 1 mM EDTA) by Amicon Ultra-4 MWCO 100K ﬁlter (Milli-
pore, Billerica, MA, USA) at 2.5 krcf for 5 min. Negative staining
was performed with 2% uranyl acetate acid on grids and viewed by
a transmission electron microscope (CM100 Biotwin, Philips/FEI
Corporation, Eindhoven, Holland).
Western blotting for IBDV-A viral particles
Puriﬁed IBDV-A viral particles (described as above) were sub-
jected to SDS-PAGE in 12.5% acrylamide gel, followed by trans-
ferring separated proteins to a Nitrocellulose membrane (Bio-Rad,
Hercules, CA, USA), Western blotting was performed using anti-
VP2 monoclonal antibody R63 (ATCC), anti-VP3 monoclonal anti-
body (Meridian, Saco, ME, USA) or anti-VP1 rabbit polyclonal
antibody (a gift from Dr. Mundt, the University of Georgia) as the
primary antibody and horseradish peroxidase (HRPO)-labeled goat
anti-mouse or goat anti-rabbit secondary antibody (KPL). The
stained protein bands were revealed by 3,30,5,50-tetra-
methylbenzidine (TMB) membrane peroxidase substrate (KPL,
Gaithersburg, MD, USA).
Genome composition of IBDV-A viral particles by agarose gel
DF-1 cells were transfected in 10 cm dishes with SegAþVP1 by
TransIT
s
-LT1 (Mirus Bio) by manufacture’s instruction. Brieﬂy,
45 ml of TransITs-LT1 was diluted in 1.5 ml OPTI-MEMs (Invitro-
gen). Then, 15 mg of each cDNA construct was added to the mix and
incubated for 15 min. Before dropwising the transfection mixture
to each dish, cell medium was replaced with fresh medium. After
75 h of incubation at 37 °C incubator, cells and supernatant were
collected by scraping, and followed by freeze-thawed for three
times. Viral particles were concentrated by SW28 rotor in a high
speed centrifuge (Optima XL-100K, Beckman Coulter) at 20 krpm
for 2 h at 4 °C. The pellet was resuspended in 200 ml of sterile
phosphate buffered saline (SPBS) and subjected to dsRNA extrac-
tion by a proteinase K method as described (Mosley et al., 2013).
Final dsRNA pellet was dissolved in 20 ml of diethyl pyrocarbonate
(DEPC)-treated water and examined in 0.6% agaorse gel (The
buffer was prepared in DEPC-treated water).
Expression of VP2 and VP1 by RT-PCR
RNAwas extracted by the proteinase K method from transected
DF-1 cells as described. RT-PCR was followed for IBDV VP2 and
VP1 gene by QIAGEN One-Step RT-PCR Kit (Qiagen, Valencia, CA,
USA) as instructed by manufacture's manual. Primers used for VP2
gene are #6 (50-ACAATCACACTGTTCTCAGCC-30) and #7 (50-
ATAGTTGCCACCGTGGATCG-30). Primers used for VP1 gene are
with primer 2304F (50-GAGTGGTCTCGTCCTTCTAGC-30) and VP1R
(50-ATCATGGCTATTGGCGGC-30).Infectivity test and immunoﬂuorescent staining
DF-1 cells in 24-wells were infected with 300 ml of collected
supernatant from SegA transfection or SegAþVP1 (IBDV-A viral
particles). After absorption for 1.5 h, medium was added to each
well and incubated for 48 h. Viral proteins in infected cells were
detected by immunoﬂuorescent staining as described previously
(Mosley et al., 2013) with anti-VP2 monoclonal antibody R63
(ATCC) or anti-VP5 rabbit polyclonal antibody (a gift from Dr.
Mundt) as the primary antibody and followed by FITC-labeled
secondary antibody (KPL).Acknowledgment
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